Try our beta test site
314 studies found for:    Open Studies | "Esophageal Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Esophageal Neoplasms" (314 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
Condition: Esophageal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Recruiting Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
3 Recruiting Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Ferumoxytol
4 Recruiting Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Radiation: IMRT simultaneous integrated boost;   Drug: Nimotuzumab;   Drug: Paclitaxel;   Drug: Nedaplatin;   Procedure: Esophagectomy
5 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Condition: Esophageal Neoplasms
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
6 Recruiting Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Device: Captivator cassette;   Other: Standard of Care
7 Recruiting Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Conditions: Esophageal Neoplasms;   Esophageal Cancer
Interventions: Radiation: Adjuvant Chemoradiation;   Radiation: Adjuvant Radiation;   Drug: Paclitaxel;   Drug: Cisplatin or Nedaplatin
8 Recruiting Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
Condition: Esophageal Neoplasms
Interventions: Drug: S1;   Drug: S-1;   Drug: irinotecan
9 Recruiting Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Radiation: 18F-FDG (Fluorodeoxyglucose) PET;   Drug: Carboplatin;   Drug: Paclitaxel
10 Not yet recruiting Low-dose Aspirin Therapy for Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Drug: Acetylsalicylic acid
11 Recruiting Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Drug: nab-paclitaxel group
12 Recruiting Genetic and Environmental Risk Factors Related to Esophageal Cancer
Condition: Esophageal Cancer
Intervention:
13 Recruiting Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer
Condition: Esophageal Carcinoma
Interventions: Other: concurrent chemoradiotherapy plus DC-CIK immunotherapy;   Other: Concurrent chemoradiation only
14 Recruiting PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Device: MRI and PET-CT
15 Recruiting Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: S-1 and Paclitaxel;   Drug: Paclitaxel and Cisplatin;   Drug: 5-FU and Cisplatin
16 Recruiting Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Device: submucosal injection needle ; EUS;   Device: ordinary endosonography(EUS)
17 Recruiting Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Other: chemoradiotherapy;   Drug: thalidomide;   Other: without thalidomide
18 Recruiting Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
Condition: Esophageal Carcinoma
Interventions: Procedure: MIE;   Procedure: OE
19 Recruiting PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Interleukin-2;   Other: PD-1 Knockout T Cells
20 Recruiting Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Radiation: Only radiation therapy;   Other: Radiation therapy plus DC-CIK cellular therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.